Uveal Melanoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Na ïve Metastatic Uveal Melanoma
Condition:   Melanoma, Uveal Interventions:   Drug: Pembrolizumab;   Drug: Lenvatinib Sponsors:   Providence Health & Services;   Merck Sharp & Dohme Corp.;   Eisai Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)
Condition:   Metastatic Uveal Melanoma Intervention:   Drug: Combination of pembrolizumab and lenvatinib Sponsors:   Institut Curie;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2022 Category: Research Source Type: clinical trials